This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The federal government and several states have implemented strategies to improve and promote OUD treatment access, especially for the relatively inexpensive and effective medication buprenorphine.
With support from the Foundation for Opioid Response Efforts (FORE), public health law experts from Indiana University McKinney School of Law and the Temple University Center for Public Health Law Research at the Beasley School of Law recently embarked on a systematic review of U.S.
trillion omnibus appropriations bill has been released by the House and Senate Appropriations Committees which, if passed, will ensure that the government remains funded until September 30, 2023. The bill must be signed by the president on Friday this week, when government funding is set to expire. The text of a $1.7
While digital health support tools provide essential supplemental care, payors continue to seek to address the indispensible need for licensed practitioners to provide mental health support to the growing number of patients in need of mental health care. 6] Increase provider reimbursement strategies. Redefining the workforce.
The proposed changes – if finalized – will not only impact HIPAA compliance , but other federal Rules that govern uses and disclosures of PHI (i.e., Update to CMS Interoperability and Patient Access Final Rule In 2020, the Centers for Medicare and MedicaidServices (CMS) published the Interoperability and Patient Access Final Rule.
This comprehensive guide aims to explore the details of MAT billing, equipping providers with the knowledge necessary to navigate this complex terrain with confidence and accuracy.
Department of Health and Human Services, who outlined the ways HHS is tailoring its approach to better serve consumers with increased cross-departmental and interdepartmental cooperation. "If you've seen one Medicaid program, you've seen one Medicaid program. And so we're very focused at HHS.
trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. These requirements would also apply to state Medicaid fee-for-service programs.
In November 2022, OCR and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) issued a Notice of Proposed Rulemaking (NPRM) which sees both Part 2 and HIPAA changes to better align these regulations. The CMS has also expanded telehealth to include all Medicare and Medicaid beneficiaries.
Department of Health and Human Services (HHS) has announced a significant restructuring initiative, undertaken in accordance with President Trump’s Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.”
1] HHS is further directed to take additional regulatory and sub-regulatory action to restrict gender-affirming care for minors, which may include changes to the Medicare and Medicaid conditions of participation or conditions for coverage, Section 1557 of the Patient Protection and Affordable Care Act and other laws and regulations.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content